Heska Corp (HSKA)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

3760 ROCKY MOUNTAIN AVENUE LOVELAND, CO 80538

Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company is focused on the canine and feline companion animal health markets. It operates in two segments: Core Companion Animal Health and Other Vaccines, Pharmaceuticals and Products. The Core Companion Animal Health segment (CCA) includes diagnostic instruments and supplies, as well as single use diagnostic and other tests, vaccines and pharmaceuticals, primarily for canine and feline use. These products are sold directly by the Company as well as through independent third-party distributors and through other distribution relationships. The Other Vaccines, Pharmaceuticals and Products segment (OVP) includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals and fish. In February 2013, it announced the acquisition of 54.6% interest of Cuattro Veterinary USA, LLC.

Data based on most recent fiscal year report
Market Cap548.864 Million Shares Outstanding7.24 Million Avg Volume137.955 Thousand
1-Yr BETA vs S&P TR1.282 Current Ratio2.45 Quick Ratio1.18
View SEC Filings from HSKA instead.

View recent insider trading info

Funds Holding HSKA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding HSKA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

293 total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

NAPOLITANO JASON A CHIEF STRATEGY OFFICER

  • Officer
62,799 2019-12-30 19

FURLONG MARK F

  • Director
45,803 2019-12-06 3

GRASSMAN CATHERINE EVP, CFO

  • Officer
1,873 2019-06-01 1

HUMPHREY SCOTT

  • Director
3,062 2019-05-30 2

WISNEWSKI NANCY EVP, DIAG. OPS & PROD. DEV.

  • Officer
46,912 2019-05-13 1

LARSON SHARON J.

  • Director
4,789 2019-05-02 1

SVEEN DAVID E.

  • Director
30,691 2019-05-02 1

TROWBRIDGE BONNIE J.

  • Director
2,039 2019-05-02 1

WILSON KEVIN S. CEO AND PRESIDENT

  • Officer
  • Director
439,232 2018-12-31 0

GORDON G IRWIN

  • Director
25,074 2018-11-29 0

MCMAHON JOHN CHIEF ACCOUNTING OFFICER

  • Officer
0 2018-10-29 0

LIPPINCOTT ROD EVP, COMP. ANIMAL HEALTH SALES

  • Officer
8,573 2018-08-31 0

ASAKOWICZ STEVE EVP, COMP. ANIMAL HEALTH SALES

  • Officer
8,400 2018-08-27 0

EYL STEVEN M. EVP, GLOBAL SALES & MARKETING

  • Officer
10,048 2018-08-09 0

AROESTY JASON D EVP, INTERNATIONAL DIAGNOSTICS

  • Officer
0 2018-07-25 0

WRENN CAROL

  • Director
5,249 2018-05-03 0

MCGINLEY MICHAEL J PRESI, BIOLOGIC. & PHARM.

  • Officer
86,776 2018-03-17 0

GRIEVE ROBERT B EXECUTIVE CHAIR

  • Officer
  • Director
106,331 2015-08-28 0

AYLESWORTH WILLIAM A

  • Director
37,397 2015-03-09 0

SASEN JOHN F E.V.P. & CHIEF MKT. OFFICER

  • Officer
No longer subject to file 2013-02-22 0

BENT MICHAEL A V.P.ACTG. OFFICER & CONTROLLER

  • Officer
9,773 2012-12-28 0

ZACHARA CLAUDINE

  • VP, MARKETING
0 2012-12-19 0

APERFINE JOSEPH EVP, SALES AND MARKETING

  • Officer
0 2012-12-19 0

CMC MASTER FUND, L.P.

CMC MASTER FUND PARTNERS, LLC

  • 10% Owner
No longer subject to file 2012-10-09 0

EIO PETER

  • Director
0 2012-05-08 0

MCCORMICK LOUISE L.

  • Director
0 2012-05-08 0

CMC MASTER FUND, L.P.

CMC MASTER FUND PARTNERS, LLC

C.M. CAPITAL ADVISORS, LLC

C.M. CAPITAL CORP

  • 10% Owner
579,045 2012-02-15 0

SNODGRASS GERALD L VP, SALES

  • Officer
0 2009-11-10 0

PACIFIC COAST INVESTORS LTD

  • 10% Owner
No longer subject to file 2009-08-25 0

FLANDERS JOHN R V.P., GENERAL COUNSEL

  • Officer
32,500 2008-11-25 0

CHARTER VENTURES II, L.P.

CHARTER VENTURES

  • 10% Owner
No longer subject to file 2008-06-20 0

RITTER JOSEPH H EVP, GLOBAL BUS. OPERATIONS

  • Officer
0 2007-12-31 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

NAPOLITANO JASON A - Officer CHIEF STRATEGY OFFICER

2019-12-30 M 147 d 0 62,799.00 direct

NAPOLITANO JASON A - Officer CHIEF STRATEGY OFFICER

2019-12-30 M 147 $39.76 a 62,699 62,799.00 direct

NAPOLITANO JASON A - Officer CHIEF STRATEGY OFFICER

2019-12-23 M 146 $39.76 a 62,611 62,652.00 direct

NAPOLITANO JASON A - Officer CHIEF STRATEGY OFFICER

2019-12-23 M 146 d 147 62,652.00 direct

NAPOLITANO JASON A - Officer CHIEF STRATEGY OFFICER

2019-12-23 F 59 $96.95 d 62,552 62,652.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments